ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma.

Brian A Van Tine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.